These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30387845)

  • 1. AHIF promotes glioblastoma progression and radioresistance via exosomes.
    Dai X; Liao K; Zhuang Z; Chen B; Zhou Z; Zhou S; Lin G; Zhang F; Lin Y; Miao Y; Li Z; Huang R; Qiu Y; Lin R
    Int J Oncol; 2019 Jan; 54(1):261-270. PubMed ID: 30387845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulated AHIF-mediated radioresistance in glioblastoma.
    Liao K; Ma X; Chen B; Lu X; Hu Y; Lin Y; Huang R; Qiu Y
    Biochem Biophys Res Commun; 2019 Feb; 509(2):617-623. PubMed ID: 30606477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of miR-96 promotes radioresistance in glioblastoma cells via targeting PDCD4.
    Guo P; Yu Y; Tian Z; Lin Y; Qiu Y; Yao W; Zhang L
    Int J Oncol; 2018 Oct; 53(4):1591-1600. PubMed ID: 30066909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Exosomal Long Noncoding RNA aHIF is Upregulated in Serum From Patients With Endometriosis and Promotes Angiogenesis in Endometriosis.
    Qiu JJ; Lin XJ; Zheng TT; Tang XY; Zhang Y; Hua KQ
    Reprod Sci; 2019 Dec; 26(12):1590-1602. PubMed ID: 30808247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of simulated hypoxia by CoCl
    Khakshour E; Bahreyni-Toossi MT; Anvari K; Shahram MA; Vaziri-Nezamdoust F; Azimian H
    Mutat Res; 2024; 828():111848. PubMed ID: 38154290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial glutamate transporter SLC25A22 uni-directionally export glutamate for metabolic rewiring in radioresistant glioblastoma.
    Shin E; Kim B; Kang H; Lee H; Park J; Kang J; Park E; Jo S; Kim HY; Lee JS; Lee JM; Youn H; Youn B
    Int J Biol Macromol; 2023 Dec; 253(Pt 8):127511. PubMed ID: 37866557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA Unigene56159 promotes glioblastoma multiforme cell proliferation and invasion through negatively regulating microRNA‑194‑5p.
    Jiang G; Dong H; Dong Y; Yang X
    Mol Med Rep; 2020 Feb; 21(2):768-776. PubMed ID: 31789416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.
    Tan SK; Pastori C; Penas C; Komotar RJ; Ivan ME; Wahlestedt C; Ayad NG
    Mol Cancer; 2018 Mar; 17(1):74. PubMed ID: 29558959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoothened Promotes Glioblastoma Radiation Resistance Via Activating USP3-Mediated Claspin Deubiquitination.
    Tu Y; Chen Z; Zhao P; Sun G; Bao Z; Chao H; Fan L; Li C; You Y; Qu Y; Chen Y; Ji J
    Clin Cancer Res; 2020 Apr; 26(7):1749-1762. PubMed ID: 31900278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44-associated radioresistance of glioblastoma in irradiated brain areas with optimal tumor coverage.
    Liu WH; Lin JC; Chou YC; Li MH; Tsai JT
    Cancer Med; 2020 Jan; 9(1):350-360. PubMed ID: 31746135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome c oxidase mediates labile iron level and radioresistance in glioblastoma.
    Ali MY; Oliva CR; Flor S; Goswami PC; Griguer CE
    Free Radic Biol Med; 2022 May; 185():25-35. PubMed ID: 35476930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of FoxO3a is associated with glioblastoma progression and predicts poor patient prognosis.
    Qian Z; Ren L; Wu D; Yang X; Zhou Z; Nie Q; Jiang G; Xue S; Weng W; Qiu Y; Lin Y
    Int J Cancer; 2017 Jun; 140(12):2792-2804. PubMed ID: 28295288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA FLVCR1‑AS1 promotes glioma cell proliferation and invasion by negatively regulating miR‑30b‑3p.
    Gao W; Li H; Liu Y; Zhang Y; Zhao H; Liu F
    Mol Med Rep; 2020 Aug; 22(2):723-732. PubMed ID: 32626942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic Cancer-Secreted Exosomal miR-182-5p Promotes Glioblastoma Angiogenesis by Targeting Kruppel-like Factor 2 and 4.
    Li J; Yuan H; Xu H; Zhao H; Xiong N
    Mol Cancer Res; 2020 Aug; 18(8):1218-1231. PubMed ID: 32366676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma.
    Alafate W; Li X; Zuo J; Zhang H; Xiang J; Wu W; Xie W; Bai X; Wang M; Wang J
    CNS Neurosci Ther; 2020 Apr; 26(4):475-485. PubMed ID: 32187449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polo‑like kinase 4 promotes tumorigenesis and induces resistance to radiotherapy in glioblastoma.
    Wang J; Zuo J; Wang M; Ma X; Gao K; Bai X; Wang N; Xie W; Liu H
    Oncol Rep; 2019 Apr; 41(4):2159-2167. PubMed ID: 30816483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.